Biomarkers of Diabetes

Biomarkers are molecular markers used as direct or indirect markers of the extent of a disease. HbA1c is considered as the biomarker in diabetes for assessing the risk factor related to retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored.

  • Novel Biomarkers
  • Advances in Molecular Diagnostics
  • HbA1c Biomarker

Related Conference of Biomarkers of Diabetes

June 27-28, 2019

18th Global Conference on Diabetes & Nursing Care

Amsterdam, Netherlands
July 05-06, 2019

12th World Congress on Diabetes & Endocrinology

Columbus, USA
July 17-18, 2019

28th European Diabetes Congress

| Edinburgh, Scotland
September 16-17, 2019

International Conference on Diabetes and Heart diseases

Athens, Greece
September 20-21, 2019

15th World Congress on Endocrinology & Diabetes

| Prague, Czech Republic
September 20-21, 2019 |

Euro Diabetes Congress & Expo

Prague, Czech Republic
October 23-24, 2019

Annual Summit on Metabolomics

Amsterdam, Netherlands
Nov 11-12, 2019

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
November 14-15, 2019

International Conference on Diabetes, Complication & Management

Brisbane, Australia
November 25-26, 2019

Annual Congress on Endocrinology, Diabetes and Healthcare

Bangkok,Thailand
December 02-03, 2019

14th European Diabetes and Endocrinology Congress

| Barcelona, Spain
Diabetes Congress 2019 | December 04-05, 2019 |

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

| Dubai, UAE
January 29-30, 2020

Global Summit On Diabetes & Endocrinology

| Holiday Inn Atrium | Singapore
Mar 25-26, 2020

29th World Diabetes & Heart Congress

| Radisson Narita | Tokyo, Japan

Biomarkers of Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in